Wiley Bros. Aintree Capital, LLC Teva Pharmaceutical Industries LTD Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 30,526 shares of TEVA stock, worth $458,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,526
Previous 33,349
8.47%
Holding current value
$458,500
Previous $600,000
12.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
673Shares Held
588MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$646 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$585 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$550 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$426 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$408 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $16.7B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...